Healthcare marketers spend more than $6.5 billion each year and depend on ad performance reporting to ensure the relevancy and effectiveness of their campaigns. Yet most patients feel like the ads they see are not relevant to them, in part because many in the industry continue to use measurement methods that delay necessary optimizations by weeks or months. DeepIntent Senior Vice President John Mangano analyzes how delayed measurement is costing healthcare marketers.